Psychiatry and Behavioral Health Conference-NAPC 2026

Major Depressive Disorder (MDD) is a prevalent mental health condition marked by persistent sadness, loss of interest in activities, and reduced ability to function in daily life. It affects millions worldwide and is a leading cause of disability.

This session explores the diagnostic criteria for MDD, including emotional, cognitive, and physical symptoms such as fatigue, sleep disturbances, and difficulty concentrating. It also discusses risk factors including genetics, environmental stressors, and life events.

The biological mechanisms underlying depression are examined, with a focus on neurotransmitters like serotonin, dopamine, and norepinephrine. Recent research into brain structure and function provides deeper insights into the disorder.

Participants will learn about evidence-based treatment options, including antidepressant medications, psychotherapy, and emerging approaches such as neuromodulation techniques. The role of lifestyle interventions is also emphasized.

Special attention is given to early detection and reducing stigma associated with mental health disorders. Strategies for improving patient engagement and adherence to treatment are also discussed.

By the end of the session, attendees will gain a well-rounded understanding of depression and practical approaches for effective management and long-term recovery.